EFFICACY AND SAFETY OF A NEW COMBINED MEDICATION WITH RECOMBINANT INTERFERON AND BETAMETHASONE IN THE TREATMENT OF HAY FEVER DURING PERIODS OF EXACERBATION
Objective: to assess the efficacy, safety and tolerability of the new combined medication Allergoferon® beta in patients with moderate-to-severe hay fever (seasonal allergic rhinitis and conjunctivitis) during periods of exacerbation. patients and methods: the object of our study was medication Alle...
Saved in:
| Main Authors: | A. A. Ryabtseva, N. Y. Sotnikova, O. V. Chumikov, N. A. Stupakova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2016-09-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/324 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Complex treatment of allergic eye diseases using interferon alfa-2b and loratadine gel for topical and external use
by: A. V. Surov,, et al.
Published: (2014-07-01) -
A study on design & development of betamethasone acetate and betamethasone sodium phosphate extended-release suspension
by: Amit Bansal, et al.
Published: (2025-06-01) -
Betamethasone latency period and neonatal hypoglycemia in term infants
by: Lauren A. Buckley, et al.
Published: (2025-12-01) -
Betamethasone administration as a treatment of choice in local post-tattoo complications
by: O. N. Karymov, et al.
Published: (2020-05-01) -
Efficacy and safety of intracameral betamethasone versus dexamethasone at the end of phacoemulsification
by: Amira F.Z. El Hewehi, et al.
Published: (2025-04-01)